<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>osteoporosis treatment &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/osteoporosis-treatment/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 05:38:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>osteoporosis treatment &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Orexin vs. Melatonin: Comparing Fracture Risk</title>
		<link>https://bioengineer.org/orexin-vs-melatonin-comparing-fracture-risk/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 05:37:50 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bone Health]]></category>
		<category><![CDATA[Fracture risk]]></category>
		<category><![CDATA[Fracture Risk Comparison]]></category>
		<category><![CDATA[Melatonin Agonists]]></category>
		<category><![CDATA[Melatonin receptor agonists]]></category>
		<category><![CDATA[Orexin Agonists]]></category>
		<category><![CDATA[Orexin receptor agonists]]></category>
		<category><![CDATA[osteoporosis]]></category>
		<category><![CDATA[osteoporosis treatment]]></category>
		<category><![CDATA[Sleep Disorder Pharmacology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/orexin-vs-melatonin-comparing-fracture-risk/</guid>

					<description><![CDATA[Recent research has shed light on the comparative fracture risk associated with orexin and melatonin receptor agonists, revealing intriguing insights that may impact treatment strategies for patients with conditions affecting bone density and overall skeletal health. In an increasingly aging population where osteoporosis and fractures are significant health concerns, the implications of these findings carry [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320172</post-id>	</item>
		<item>
		<title>Intermittent Hypobaric Pressure Fights Aging and Osteoporosis</title>
		<link>https://bioengineer.org/intermittent-hypobaric-pressure-fights-aging-and-osteoporosis/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 14 Jan 2026 16:27:34 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[aging research]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket: **intermittent hypobaric pressure]]></category>
		<category><![CDATA[osteoporosis treatment]]></category>
		<category><![CDATA[regenerative medicine** **Açıklama:** 1. **intermittent hypobaric pressure:** Makalenin temel konusu ve araştırılan tedavi yöntemi. Doğrudan başlıkta ve içerikte vurgulanıyor. 2. **]]></category>
		<category><![CDATA[senescent cells]]></category>
		<guid isPermaLink="false">https://bioengineer.org/intermittent-hypobaric-pressure-fights-aging-and-osteoporosis/</guid>

					<description><![CDATA[Recent research has unveiled a groundbreaking approach to combating age-related osteoporosis through the application of intermittent hypobaric pressure. Conducted by a team of innovative scientists, this study proposes a novel mechanism for inducing selective senescent cell death, a critical aspect in the aging process, particularly in bone health. The detrimental effects of senescent cells on [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316877</post-id>	</item>
	</channel>
</rss>
